{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-314767","form_type":"8-K","ticker":"STIM","cik":"0001227636","company_name":"Neuronetics, Inc.","filed_at":"2022-12-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:49.883805+00:00","generated_at":"2026-06-20T21:47:59.468534+00:00","sec_items":["5.02","5.03","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Neuronetics appoints Joseph H. Capper to board, adopts amended bylaws","bullets":["Joseph H. Capper appointed to board and Audit Committee effective Jan 1, 2023; term expires at 2023 annual meeting.","Capper qualifies as independent under SEC and Nasdaq rules.","Fourth Amended and Restated Bylaws adopted to update for universal proxy rules and administrative changes.","Capper has no family relationships with directors/executives and no material interest in transactions.","Capper to receive standard non-employee director compensation per 2022 proxy statement."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-314767","json":"https://secwatch.observer/filing/0001193125-22-314767.json","markdown":"https://secwatch.observer/filing/0001193125-22-314767.md","text":"https://secwatch.observer/filing/0001193125-22-314767.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1227636/000119312522314767/0001193125-22-314767-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1227636/000119312522314767/d439589d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T21:47:59.468534+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b013554c29","claim":"Joseph H. Capper was appointed as Director at Neuronetics, Inc..","evidence_excerpt":"appointed Joseph H. Capper as a director and member of the Board’s Audit Committee effective January 1, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1227636/000119312522314767/0001193125-22-314767-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"536fa29a96a8dd11541ad3f960fca0caf192a3a2","claim":"Neuronetics, Inc.: Adopted Fourth Amended and Restated Bylaws updating provisions for universal proxy rules and making administrative changes (effective 2022-12-27).","evidence_excerpt":"On December 27, 2022, the Board voted to adopt the Fourth Amended and Restated Bylaws (the “A&R Bylaws”), which became effective immediately upon adoption. The A&R Bylaws amend and restate the Company’s previously existing bylaws in their entirety to, among other things, (i) update provisions as a result of universal proxy rules adopted by the SEC with respect to the nomination of directors for election, including a requirement for a stockholder submitting a nomination notice to make a representation as to whether such stockholder intends to solicit proxies in support of director nominees other than the Company’s nominees in accordance with Rule 14a-19 under the Securities Exchange Act of 1934, as amended, and to provide reasonable evidence that certain requirements of such rule have been satisfied; and (ii) make certain other administrative, modernizing, clarifying and conforming changes.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1227636/000119312522314767/0001193125-22-314767-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2022-12-27"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}